Digg It - Business

It is a sad statistic, but most companies lose track of between 40 and 80 percent of their leads at some point in the sales cyc

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

le. This fact shows that many companies face a wide variety of challenges in lead tracking. Finding a lead is viewed by some as

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

the more difficult task, but in reality, most companies have more difficulty keeping and acting upon the lead.

To begin with,

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

lead capture is essential to lead tracking. There are specific business rules that should be followed when capturing a lead, an

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

if those rules are not defined well in the beginning, it will be harder to hold onto the lead. If a business starts a relation

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ship of with a consumer on a bad note, then that business is less likely to keep that consumer interested for a long period of

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ime.

Some companies simply lose track of their leads. Finding and implementing the right software can often be a challenge for

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

a company interested in tracking and managing their leads. New systems are coming out that attempt to provide the company with

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

end-to-end visibility. However, it is the responsibility of the company to stay with the most current (and efficient) lead trac

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

king technology. After spending so much time and effort finding a lead, it is very foolish to allow that lead to be dropped bec

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

use of bad software.

The best programs have a very organized system of dealing with leads. Different types of leads are treate

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

d differently, as they should be. Spending the same amount of resources and devoting the same amount of time to different leads

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

is very inefficient. Companies that have success attribute leads to a specific marketing investment; they also give different a

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ttention to hot, warm, and cool leads. High-priority leads go immediately to sales, and lower priority leads go to marketing fo

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

future attention. Companies that succeed have great systems for notifying management when a lead is not being attended to and

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

gather more results for an accurate evaluation of market activities.

It is easy to identity the challenges associated with lea

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

tracking, but it is difficult for most companies to respond to those challenges. The best way to respond is to have a clearly

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

defined, ethical business plan for dealing with leads. Additionally, having experienced employees who can deal with leads well

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

s very helpful. However, better lead tracking can happen if highly skilled employees have access to the right tools. Thus top-t

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ier lead management solutions offered by companies such as Leads360 can help companies become much more productive in this area

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/23000/diggit-Challenges-in-Lead-Tracking.html">Challenges in Lead Tracking</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/23000/diggit-Challenges-in-Lead-Tracking.html]Challenges in Lead Tracking[/url]

Branding is one of the hottest buzzwords in business. But what is it? Branding is basically building consumer trust and offering an expected product or service to generate loyalty. Research shows that customers will be loyal to a brand. Learn how to build your own customer loyal brand.

What does an oasis, scorpion and a kind traveler have to teach us about customer service? More than you think.

The healthcare industry is one industry that could really benefit from Six Sigma implementation. Read this article to find out how and why.

Tags

Links

Digg It - Challenges in Lead Tracking

Related Articles: